{"filing":{"accession_number":"0001654954-26-006706","cik":"0001131399","ticker":"GLAXF","company_name":"GSK plc","form":"6-K","filing_date":"2026-07-17","report_date":null,"primary_document":"a8186m.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1131399/000165495426006706/a8186m.htm"},"events":[{"id":18574,"run_id":16699,"accession_number":"0001654954-26-006706","anchor_item_number":null,"event_type":"auditor_change","event_domain":"governance","is_material":true,"confidence":0.92,"summary":"GSK announces the Board's decision to re-appoint Deloitte LLP as external auditor following a competitive tender process required by Public Interest Entity rules. Although technically a re-appointment rather than a change to a new firm, the announcement of the auditor selection outcome following a formal tender process is a material governance event requiring shareholder approval at the 2028 AGM, consistent with auditor_change classification.","company_name":"GSK plc","ticker":"GLAXF","filing_date":"2026-07-17","form":"6-K","submitted_at":null,"items":null}],"classifications":[{"id":17420,"accession_number":"0001654954-26-006706","item_number":null,"item_title":null,"event_type":"auditor_change","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"GSK announces the Board's decision to re-appoint Deloitte LLP as external auditor following a competitive tender process required by Public Interest Entity rules. Although technically a re-appointment rather than a change to a new firm, the announcement of the auditor selection outcome following a formal tender process is a material governance event requiring shareholder approval at the 2028 AGM, consistent with auditor_change classification.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-17T11:15:36.700449+00:00","company_name":"GSK plc","ticker":"GLAXF","filing_date":"2026-07-17"}]}